Orthofix International N.V. (NASDAQ:OFIX) – Stock analysts at Gabelli raised their FY2018 EPS estimates for Orthofix International N.V. in a research note issued on Wednesday. Gabelli analyst J. Tsai now forecasts that the medical device company will earn $1.70 per share for the year, up from their prior forecast of $1.65. Gabelli also issued estimates for Orthofix International N.V.’s FY2020 earnings at $2.05 EPS and FY2021 earnings at $2.20 EPS.

Other equities analysts have also recently issued research reports about the stock. TheStreet raised shares of Orthofix International N.V. from a “c+” rating to a “b-” rating in a research report on Tuesday. BTIG Research initiated coverage on shares of Orthofix International N.V. in a research report on Wednesday, June 21st. They set a “buy” rating and a $52.00 price objective on the stock. Langenberg & Company reissued a “buy” rating and set a $53.25 price objective on shares of Orthofix International N.V. in a research report on Wednesday, June 14th. Ladenburg Thalmann Financial Services initiated coverage on shares of Orthofix International N.V. in a research report on Wednesday, June 14th. They set a “buy” rating and a $53.25 price objective on the stock. Finally, SunTrust Banks, Inc. initiated coverage on shares of Orthofix International N.V. in a research report on Tuesday, May 23rd. They set a “buy” rating and a $49.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Orthofix International N.V. presently has an average rating of “Buy” and an average target price of $52.75.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://www.watchlistnews.com/orthofix-international-n-v-ofix-to-post-fy2018-earnings-of-1-70-per-share-gabelli-forecasts/1468715.html.

Shares of Orthofix International N.V. (OFIX) traded down 0.95% during mid-day trading on Thursday, reaching $46.90. The company had a trading volume of 47,627 shares. The firm’s 50-day moving average is $45.59 and its 200 day moving average is $40.76. Orthofix International N.V. has a 12 month low of $32.51 and a 12 month high of $49.60. The company has a market capitalization of $852.17 million, a price-to-earnings ratio of 109.84 and a beta of 0.25.

Orthofix International N.V. (NASDAQ:OFIX) last announced its earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a return on equity of 9.96% and a net margin of 1.88%. The firm had revenue of $108.90 million during the quarter, compared to the consensus estimate of $102.94 million. During the same quarter in the prior year, the company earned $0.41 EPS. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year.

Large investors have recently bought and sold shares of the company. Wellington Management Group LLP acquired a new stake in Orthofix International N.V. during the first quarter worth $20,021,000. Vanguard Group Inc. raised its stake in Orthofix International N.V. by 18.6% in the first quarter. Vanguard Group Inc. now owns 1,815,948 shares of the medical device company’s stock worth $69,278,000 after buying an additional 284,482 shares in the last quarter. Teachers Advisors LLC raised its stake in Orthofix International N.V. by 676.2% in the first quarter. Teachers Advisors LLC now owns 276,340 shares of the medical device company’s stock worth $10,542,000 after buying an additional 240,740 shares in the last quarter. Norges Bank acquired a new stake in Orthofix International N.V. during the fourth quarter worth $5,664,000. Finally, Paradice Investment Management LLC acquired a new stake in Orthofix International N.V. during the second quarter worth $6,642,000. Institutional investors own 99.68% of the company’s stock.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Earnings History and Estimates for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.